5-fluoro-2,2'-cyclocytidine has been researched along with busulfan in 1 studies
*Busulfan: An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [MeSH]
*Busulfan: An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [MeSH]
Studies (5-fluoro-2,2'-cyclocytidine) | Trials (5-fluoro-2,2'-cyclocytidine) | Recent Studies (post-2010) (5-fluoro-2,2'-cyclocytidine) | Studies (busulfan) | Trials (busulfan) | Recent Studies (post-2010) (busulfan) |
---|---|---|---|---|---|
5 | 1 | 0 | 4,967 | 645 | 1,426 |
Protein | Taxonomy | 5-fluoro-2,2'-cyclocytidine (IC50) | busulfan (IC50) |
---|---|---|---|
Matrix metalloproteinase-9 | Homo sapiens (human) | 5.215 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Floersheim, GL; Torhorst, J | 1 |
1 other study(ies) available for 5-fluoro-2,2'-cyclocytidine and busulfan
Article | Year |
---|---|
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer Cells, Natural; Leukemia, Experimental; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Moloney murine leukemia virus; Neoplasms, Experimental; Sarcoma, Experimental | 1981 |